- Home
- KFFB vs DARE Comparison
KFFB vs DARE Comparison
Compare KFFB & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KFFB | DARE |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 33.4M |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KFFB | DARE |
|---|---|---|
| Price | $4.79 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 1.3K | ★ 321.3K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.52 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $15,000.00 | ★ $2,807,885.00 |
| Revenue This Year | N/A | $2,115.12 |
| Revenue Next Year | N/A | $122.62 |
| P/E Ratio | $31.93 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.51 | $1.27 |
| 52 Week High | $4.98 | $9.19 |
Technical Indicators
Market Signals| Indicator | KFFB | DARE |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 44.15 |
| Support Level | $4.26 | $1.94 |
| Resistance Level | $4.86 | $2.22 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 83.87 | 27.69 |
Price Performance
Historical ComparisonAbout KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.